Research

lf0 Research Notes

Get future lf0 equity research notes by email.

Weekly stock analysis, SEC filing-change summaries, and quant strategy notes from lf0.

Subscribe to lf0 Research Notes

Equity Research
ADTN
Adtran Holdings Stock Analysis: Buy or Sell? Valuation, Margins & Cash Flow
Aug 11, 2026
ADTRAN Holdings (ADTN) is rated Sell as revenue keeps drifting lower and cash conversion remains thin. The stock trades below some richer peers, but weak operating margins, modest free cash flow, and leverage keep the risk/reward unattractive.
Read note
Equity Research
STZ
Constellation Brands Stock Analysis: Buy or Sell? Valuation, Cash Flow & Margins
Aug 11, 2026
Constellation Brands (STZ) is rated Hold as strong free cash flow and a 9.7% yield support the stock, but revenue is still slipping. The valuation is reasonable, yet not cheap enough to ignore the growth gap and $10.5B of net debt.
Read note
Equity Research
RELY
Remitly Global Stock Analysis: Buy or Sell? Valuation, Growth, Margins & Cash Flow
Aug 11, 2026
Remitly Global (RELY) is rated Hold as solid revenue growth is offset by a valuation that already discounts much of the progress. Cash and low debt support the balance sheet, but insider selling and only gradual earnings conversion keep the setup mixed.
Read note
Equity Research
CLOV
Clover Health Stock Analysis: Buy or Sell? Valuation & Margins, Cash Flow
Aug 10, 2026
Clover Health Investments Corp. (CLOV) is rated Hold after its first profitable quarter, but trailing margins and free cash flow still lag. The business needs sustained revenue and EBITDA improvement before the new inflection looks durable.
Read note
SEC What Changed
SEC
SEC What Changed: 10-K Filing Snapshot for 10 August 2026
Aug 10, 2026
A ranked snapshot of 10-K language changes for companies that filed annual reports on 10 August 2026.
Read note
Equity Research
WGS
GeneDx Stock Analysis: Buy or Sell? Valuation, Cash Flow & Margins
Aug 9, 2026
GeneDx Holdings Corp. (WGS) is rated Sell as the market prices in a clean earnings recovery that cash flow and margin trends do not yet support. Revenue growth is improving, but positive free cash flow remains elusive and reimbursement pressure could delay a rerating.
Read note
Equity Research
HST
Host Hotels & Resorts Stock Analysis: Buy or Sell? Valuation, FCF & Leverage
Aug 9, 2026
Host Hotels & Resorts (HST) is rated Hold as its cash-flow cushion and 10.5% FCF yield help support the equity. However, the stock already prices in a fair recovery, while leverage and hotel margin improvement remain the key debate.
Read note
Equity Research
EPAM
EPAM Systems Stock Analysis: Buy or Sell? AI Demand, Growth & Margins
Aug 8, 2026
EPAM Systems (EPAM) is rated Hold, supported by a strong cash profile and a net cash balance sheet. Modest growth and geopolitical delivery risk keep the multiple from expanding despite a 12.9% FCF yield.
Read note
SEC What Changed
CLX, CMPR, LRCX, NWSA, RSKIA
Clorox (CLX) 10-K Changes Lead 7 August 2026 Filing Roundup
Aug 7, 2026
Clorox (CLX) led the biggest 10-K filing change among 5 companies that filed annual reports on 7 August 2026, each compared against its prior-year 10-K.
Read note
Equity Research
APP
AppLovin Stock Analysis: Buy or Sell? Valuation & Privacy Risk
Aug 6, 2026
AppLovin (APP) earns a Hold rating as its ad platform quality and cash generation are strong, but the valuation already prices in a long growth runway. The main tension is whether revenue growth can stay elevated while privacy changes and platform dependence remain manageable.
Read note

Get future lf0 research notes by email.

Equity research, SEC filing-change summaries, and quant research — delivered when published. Free, no noise.

Subscribe to lf0 Research Notes

No spam. Unsubscribe anytime.